Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2001
11/08/2001WO2001038564A3 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
11/08/2001WO2001038558A3 Age-corrected mmp-assay for malignant pathologies
11/08/2001WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
11/08/2001WO2001033188A8 Assay method for determining product r's effect on adenovirus infection of hela cells
11/08/2001WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001WO2001029068A3 A eag gene encoding for a potassium channel
11/08/2001WO2001023609A3 Hybridization probes which detect bacteria of the genus thermobifida
11/08/2001WO2001018240A3 Diagnostic and therapeutic methods in autoimmune disease
11/08/2001WO2001018035A3 Muc-1 derived peptides
11/08/2001WO2001008707A3 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/08/2001WO2001002551A3 Virus like particles, preparation and use in screening and functional genomics
11/08/2001WO2000079008B1 High throughput assay system
11/08/2001WO2000066607A9 Detection using degradation of a tagged sequence
11/08/2001WO2000042221A9 Method for the affinity isolation of newly synthesized rna
11/08/2001WO2000042209A9 Methods and apparatus for detecting polynucleotide hybridization
11/08/2001WO2000002045A3 Bioluminescent assay for agonists or antagonists of a calcium-coupled receptor
11/08/2001WO1999051621A3 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
11/08/2001US20010039334 Hybrids
11/08/2001US20010039072 Reactive probe chip, composite substrate and method for fabrication of the same
11/08/2001US20010039057 Devices for testing for the presence and/or concentration of an analyte in a body fluid
11/08/2001US20010039040 Electrolytic control of metal ion activity providing a tool for the repetitive isothermal denaturation of duplex DNA and so can be used as a substitute for thermal cycling which allows for a wide range of polymerases to be used
11/08/2001US20010039039 Methods for selectively isolating DNA using rolling circle amplification
11/08/2001US20010039038 Novel glucosaminidase
11/08/2001US20010039035 Enhancing the reaction of a conjugate comprising a detectably labeled phenol substrate with a peroxidase by reacting in the presence of an inorganic compound e.g. NACl, and an organic compound, e.g. p-iodophenol; signal amplification immunoassay
11/08/2001US20010039034 Method for labeling individual cells
11/08/2001US20010039033 Method and apparatus for detecting microorganisms, and quantities of microorganisms
11/08/2001US20010039032 Concurrent determination of micorganism identity; disposable plates and wells inoculated with a microorganism and antibiotic which may be presented a a concentration gradient; urine screening; visability; computers
11/08/2001US20010039031 Summarily identifying the species the microorganism belongs to and measuring the minimum inhibitory concentrations of several antimicrobial agents for the microorganism; frequency distribution of minimum inhibitory concentrations; databases
11/08/2001US20010039030 Testing the biocidal efficacy of a liquid sterilant using a vessel connected to an inlet and containing a known quantity of microorganisms, the inlet being separated by a porous filter to retain the microbes; disposable syringes
11/08/2001US20010039029 To diagnose activity of cancer cells, progress of periodontal diseases, e.g. alveolar pyorrhea, and rheumatoid arthritis; detecting digestion traces on a thin colored membrane contacted with protease-containing tissue or serum
11/08/2001US20010039024 Process for identifying and enriching cell-specific target structures
11/08/2001US20010039023 Process for identifying cell-specific target structures
11/08/2001US20010039022 Quantitative analysis; mesuring pattern of structural changes induced in eukaryotic cells
11/08/2001US20010039018 Immobilization of unmodified biopolymers to acyl fluoride activated substrates
11/08/2001US20010039017 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
11/08/2001US20010039016 Measurement, calibration gene expression
11/08/2001US20010039015 Nipple aspirate fluid specific microarrays
11/08/2001US20010039014 Integrated systems and methods for diversity generation and screening
11/08/2001US20010039013 Screening, diagnosis cancer
11/08/2001US20010039012 Analyzing, calibration sample of tissue
11/08/2001US20010039008 Immunofluorescence
11/08/2001US20010039007 Human t-cell lymphotrophic virus
11/08/2001US20010039006 Libraries
11/08/2001US20010038845 Parenterally administering large liposomes comprised of phospholipids free of sterol which pick-up cholesterol druing the treatment period; liposomes too large to penetrate fenestrations of endothelial lining hepatic sinusoids
11/08/2001US20010038842 Treating a disease characterized by expression of vascular endothelial growth factor-D (VEGF-D) by a tumor by screening for a VEGF-D expressing tumor, administering a VEGF-D antagonist to prevent binding of VEGF-D to its receptor
11/08/2001US20010038837 Introducing non-tumorogenic skeletal myoblasts or cardiomyocytes in myocardial tissue of the animal so as to form a stable myocardial graft, can be used, to deliver recombinant proteins directly to the heart
11/08/2001US20010038070 Multiplex sequence variation analysis of DNA samples by mass spectrometry
11/08/2001EP1144429A3 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
11/08/2001DE10106643A1 Detection probes used in bioassays e.g. for determining nucleic acids, based on luminescent doped inorganic nanoparticles which are detectable after irradiation source and can be coupled to affinity molecules
11/08/2001DE10021947A1 Detecting nucleic acid by in situ hybridization, useful for detecting microorganisms, with addition of helper probes to increase target accessibility
11/08/2001DE10021204A1 Verfahren zur hochparallelen Analyse von Polymorphismen A method for highly parallel analysis of polymorphisms
11/08/2001DE10020704A1 Biochip zur Archivierung und labormedizinischen Analyse von biologischem Probenmaterial, Verfahren zu dessen Herstellung sowie dessen Verwendung in diagnostischen Verfahren Biochip for archiving medical and laboratory analysis of biological sample material, process for its preparation and its use in diagnostic methods
11/08/2001DE10019289A1 Method for detecting cocoa components in cocoa products, useful e.g. for quality control, comprises amplifying a new husk-specific DNA
11/08/2001CA2689946A1 In situ growth, freezing and testing of cultured cells
11/08/2001CA2414296A1 Anti-inflammatory compounds and uses thereof
11/08/2001CA2414290A1 Anti-inflammatory compounds and uses thereof
11/08/2001CA2409686A1 Serine-threonine kinase
11/08/2001CA2408263A1 Method and probes for the genetic diagnosis of hemochromatosis
11/08/2001CA2408105A1 Novel proteases
11/08/2001CA2408094A1 Colloid compositions for solid phase biomolecular analytical, preparative and identification systems
11/08/2001CA2408073A1 Nucleic acids encoding a novel regulator of a g protein signaling, rgs18, and uses thereof
11/08/2001CA2408003A1 Gamma secretase substrates and in vitro assays
11/08/2001CA2407970A1 A method for activating only the vascular endothelial growth factor receptor-3 and uses thereof
11/08/2001CA2407959A1 Human wingless-like gene
11/08/2001CA2407906A1 Method for screening agent acting on cell wall
11/08/2001CA2407893A1 New gtpase-activating protein 1
11/08/2001CA2407887A1 Natrium-calcium exchanger protein
11/08/2001CA2407834A1 Method of identifying agents that alter the activity of the promoter sequence for corticotropin releasing-factor receptor crf 2-alpha
11/08/2001CA2407753A1 Method for the detection of minority genomes in virus quasispecies using dna microchips
11/08/2001CA2407746A1 Proteases
11/08/2001CA2407737A1 Regulatory nucleic acid for the abc1 gene, molecules modifying its activity and therapeutic uses
11/08/2001CA2407731A1 Identification of genetic markers
11/08/2001CA2407701A1 Micro-array evanescent wave fluorescence detection device
11/08/2001CA2407695A1 Methods for binding an exogenous molecule to cellular chromatin
11/08/2001CA2407656A1 Myocardial cell proliferation-associated genes
11/08/2001CA2407604A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001CA2407601A1 Novel human phospholipase c delta 5
11/08/2001CA2407460A1 Targeted modification of chromatin structure
11/08/2001CA2407435A1 Rna metabolism proteins
11/08/2001CA2407399A1 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/08/2001CA2407396A1 Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots
11/08/2001CA2407272A1 Method and composition for analyzing a carbohydrate polymer
11/08/2001CA2407226A1 Polynucleotide probes for detection and quantitation of candida species
11/08/2001CA2407219A1 Pain signaling molecules
11/08/2001CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001CA2406724A1 Device and method for integrated diagnostics with multiple independent flow paths
11/08/2001CA2405952A1 Novel assay for nucleic acid analysis
11/08/2001CA2405363A1 Epitope synchronization in antigen presenting cells
11/08/2001CA2403901A1 29 human secreted proteins
11/08/2001CA2324982A1 Method for examining disease
11/07/2001EP1152370A2 Control of nucleic acid amplification procedures including the polymerase chain reaction (PCR)
11/07/2001EP1152239A1 Biosensor, method of forming thin-film electrode, and method and apparatus for quantitative determination
11/07/2001EP1152063A1 Method of diagnosing HBV infection stages
11/07/2001EP1152062A2 High temperature reverse transcription using mutant DNA polymerases
11/07/2001EP1152061A1 Development of method for screening physiologically active pyrrole imidazole derivative
11/07/2001EP1152055A1 ADAMTS polypeptides, nucleic acids encoding them, and uses therof
11/07/2001EP1152008A2 Fluorescent nucleotides containing a cyanine, merocyanine or styryl dye for the detection of nucleic acid
11/07/2001EP1151306A1 High throughput mass spectrometry
11/07/2001EP1151305A1 Prion test
11/07/2001EP1151303A1 Screening methods